Cytokinetics, Incorporated

Q2 2020 13F Holders

Symbol
CYTK
CUSIP
23282W605
Type
Equity
Class
COM NEW
Num filings
170
Total reported value, excl. options
$1.36 B
Manager Report Date Value ($000) Shares Option Type